As melanoma cells can preferentially use a combination of glycolysis and oxidative phosphorylation, examining when to suppress (countering respiration-dependent growth) or induce (targeting weaknesses in ROS detoxification in treatment-resistant melanomas) SIRT3 could be helpful. The gene discussed is SIRT3; the disease is melanoma.